Identifying the genetic factors that contribute to memory and learning is limited by the complexity of brain development and the lack of suitable human models for mild disorders of cognition. Methods: Previously, a disease locus was mapped for a mild type of nonsyndromic mental retardation (IQ between 50 and 70) to a 4.2-MB interval on chromosome 3p25-pter in a large kindred. The genes and transcripts within the candidate region were systematically analyzed for mutations by single-strand polymorphism analysis and DNA sequencing. Results: A nonsense mutation causing a premature stop codon in a novel gene (cereblon; CRBN) was identified that encodes for an ATP-dependent Lon protease. The predicted protein sequence is highly conserved across species, and it belongs to a family of proteins that selectively degrade short-lived polypeptides and regulate mitochondrial replication and transcription. One member of the Lon-containing protein family is regionally expressed in the human hippocampus, an important neuroanatomic region that is involved in long-term potentiation and learning. The mutation in the CRBN gene described interrupts an N-myristoylation site and eliminates a casein kinase II phosphorylation site at the C terminus. Conclusions: A gene on chromosome 3p that is associated with mild mental retardation in a large kindred is reported. This finding implicates a role for the ATP-dependent degradation of proteins in memory and learning.
The identification of specific human genetic disorders that affect critical steps in cognition has greatly facilitated our understanding of the molecular mechanisms involved in learning and memory. Research in this field is particularly important because developmental disorders of cognition or mental retardation affects approximately 1 to 3% of the general population in the United States. 1 A genetic or inherited metabolic etiology is implicated in two-thirds of mental retardation cases, 2 and a recessive mode of transmission accounts for nearly one-fourth of these cases. [3] [4] [5] About one-third of mental retardation is considered severe (IQ Ͻ 50). 6 The genetic disorders studied thus far are suboptimal models to unravel the fundamental aspects of human cognition because they are either severe 7 or are part of a syndrome with extensive involvement of other processes besides memory and learning. 8 Several of these syndromes affect basic cellular mechanisms such as signaling pathways, [9] [10] [11] [12] regulation of gene expression, [13] [14] [15] [16] [17] and alterations in hippocampal dendrite morphology. 18 Previously, we described a genetic locus for autosomal recessive nonsyndromic mental retardation (ARNSMR) on chromosome 3p. 19 This locus, designated as MRT2A (MIM 607417), is associated with a mild ARNSMR phenotype with IQs ranging from 50 to 70. The phenotype does not include congenital anomalies or dysmorphic features. 19 A 4.2-MB physical map of the MRT2A candidate region contains five transcripts and nine genes. The nine genes with known function were excluded as a cause of ARNSMR by single-strand conformational polymorphism (SSCP) analysis followed by direct DNA sequencing of the PCR products. 20 In this article, we exclude four of the five transcripts as a cause for mild ARNSMR and report that a nonsense mutation in a novel gene that encodes for an ATP-dependent Lon protease is responsible for mild cognitive deficits.
Methods. Research subjects. This research study was approved by the Mid-Hudson Family Health Institute Institutional Review Board. Written informed consent was obtained from each individual before genetic analyses. High molecular weight genomic DNA was isolated by using the Puregene DNA extraction kit (Gentra Systems, Minneapolis, MN). DNA from five nuclear families with a mild type of ARNSMR and from 100 normal white control subjects (200 chromosomes) was used to identify mutations in the 11 coding regions of the human CRBN gene.
Genealogic information. To identify a gene that causes a mild ARNSMR, we compiled a database using seven volumes of genealogic information to establish the relationships among individuals belonging to a sectarian population. This population traces their ancestry to 12 separatists who immigrated to North America in the late 17th century to escape religious persecution in Western Europe. Their descendants have remained in the same county in the United States (1990 US census: 29,296 inhabitants) for over two centuries. In this population, 10 individuals from three branches of an extended pedigree were diagnosed with ARNSMR. 19 Phenotype assignment. State-licensed school psychologists evaluated the cognitive function of the affected individuals by administering standardized tests between the ages of 6 and 12. The composite scores on the Stanford-Binet Test ranged from 50 to 70, indicating that all individuals were cognitively disabled in the mildly mentally retarded range. IQ scores were lower in males than females. 19 There were no prior histories of pre-or postgestational complications in affected individuals. None of the affected individuals had peri-or postnatal infections, afebrile seizures, toxic exposures, or significant head trauma. Developmental milestones were mildly delayed since early childhood. Hearing and vision screening were normal. There was good eye contact and no autistic features. The highest reading ability achieved was at the first-grade level in a 32-year-old affected woman as assessed by the Gray Oral Reading Scale. In five affected adult individuals, writing skills were limited to signing their own names. None of the other affected individuals could write. The dysmorphologic examination included inspection for craniofacial, thoracoabdominal, digital, and limb anomalies and standard anthropologic measurements of the head, eyes, ears, philtrum, limbs, and digits. Detailed physical and neurologic examinations in all study participants did not show microcephaly, organomegaly, phakomata, spasticity, weakness, neuropathy, visual deficits, feeding problems, or psychiatric disorders. All individuals had normal newborn screening examinations for hypothyroidism, galactosemia, maple syrup urine disease, phenylketonuria, and biotinidase. Affected individuals had normal laboratory studies on the following: MRI of the brain, high-resolution (ISCN G-banding 550 resolution) cytogenetic studies, DNA testing for a CCG repeat expansion in fragile X, fasting plasma amino acids, urine amino acids and organic acids, pyruvate, lactate, and ammonia. The intellectual level of each unaffected person was judged to be normal by a bedside appraisal of memory, judgment, general knowledge, and calculation ability. 21 None of the unaffected individuals had developmental delay or learning disabilities as children, and they were judged to be of normal intelligence by psychometric testing performed during grade school.
PCR SSCP. Intronic PCR primers flanking the splice sites of each coding regions of the CRBN gene were synthesized on an ABI DNA Synthesizer 3900 (Foster City, CA). The forward primer 5'-ACTTAGGTATGTATCAGAGG-3' and reverse primer 5'-ATATGATAGGCTTGGAGTAC-3' were used to amplify the CRBN exon 11 fragment. The PCR reaction contained 100 ng of genomic DNA in a total volume of 15 L with 0.8 mM of each primer, 0.2 mM of each dNTP, 100 mM Tris-HCl (pH 9.0), 500 mM KCl, 15 mM MgCl 2 , and 0.5 U of Taq polymerase (Sigma Aldrich, St. Louis, MO). The reactions were performed in a 96-well microtiter plate on a Genius thermocycler (Techne, Princeton, NJ). Amplification was carried out with an initial denaturation step of 5 minutes at 95°C followed by 30 cycles of denaturation for 45 seconds at 95°C, 45 seconds of annealing at varying temperatures, and 45 seconds of extension at 72°C. The last extension step was 7 minutes at 72°C. The PCR products of nine affected individuals were compared with 200 normal controls for differences in DNA mobility shifts by SSCP, as published previously.
DNA sequencing. When differences in SSCP were found between affected and controls, the samples were sequenced to define the nucleotide variation causing the mobility shift, as published previously. 20 Restriction enzyme digestion. The identification of a change in the wild-type nucleotide sequence 5'-ACGC-3' to the mutant 5'-ACGT-3' sequence (figure 1) caused an insertion of an HpyCH4IV restriction enzyme site in CRBN exon 11. Restriction enzyme digests were carried out using the instructions provided by the manufacturer (New England BioLabs, Beverly, MA) and electrophoresed on a 2% agarose/0.1% ethidium bromide gel. Gels were visualized on an ultraviolet light box.
Reverse transcription PCR. Reverse transcription PCR was performed using the instructions for One Step RT-PCR provided by the manufacturer (USB Co., Cleveland, OH). The oligonucleotide primers were designed in regions that overlapped the coding regions of the CRBN gene to prevent amplification of genomic DNA. One microgram of total RNA was used in the reaction with 0.4 M of the primer 5'-TTTGGGGGTAAACAGACATGGC-3' to reverse transcribe. Amplification was performed using the sense 
Carriers show two bands representing the 331-bp wild-type allele and the cleaved mutant allele (164-bp, 167-bp) (lanes 3 to 6). The mutation creates a restriction site so that the amplified 331-bp fragment is cleaved in half (164-bp, 167-bp) (lanes 7 to 10).
primer 5'-TTTGGGGGTAAACAGACATGGC-3' and antisense primer 5'-ATGGCACCAAGCTACCCAAGTAGATG-3'. Reverse transcription was performed at 43°C for 30 minutes. PCR amplification was performed with an initial denaturation step of 3 minutes at 95°C followed by 40 cycles of denaturation for 30 seconds at 95°C, 30 seconds of annealing at 60°C, and 120 seconds of extension at 72°C. The last extension step was 3 minutes at 72°C. The products were visualized with ethidium bromide on 1.2% agarose gel.
GenBank accession nos. The DNA and protein sequences are as follows: CRBN, NM_016302; PRSS15, NM_004793; Homo sapiens CRBN, NP_057386; Mus musculus CRBN, NP_780566; and Rattus norvegicus CRBN, XP_216255.
Results. Mutational analysis of candidate transcripts and genes.
A genome-wide search established genetic linkage between loci on chromosome 3p24-pter and a ARNSMR locus in the population isolate. 19 Homozygosity mapping narrowed the genetic interval to a 4.2-millionbase-pair region between loci D3S3630 and D3S1304. 20 This interval contained five transcripts (LOC51185, LOC375321, LOC132049, LOC377019, and FLJ10702) and nine genes (IL5RA, TRNT1, LRRN1, SETMAR, SUMF1, ITPR1, BHLHB2, EDEM, and MRPS36P1). The coding regions and splice sites of these genes and transcripts were analyzed systematically for mutations by SSCP analysis followed by direct DNA sequencing of the PCR products. The nine genes with known function were excluded by these methods as a cause of mental retardation in our sample. SSCP analysis of the transcripts revealed a variation in LOC51185 that segregated with the disease phenotype (see figure 1A) . The other transcripts did not have any DNA sequence variations by SSCP and DNA sequencing.
Identification of truncating mutation in mild ARNSMR. DNA sequencing of the LOC51185 PCR product in affected individuals detected a homozygous C3 T nonsense mutation at nucleotide position 1,274 of the LOC51185 cDNA (1,274C3 T). This substitution changed an arginine residue to a stop codon (see figure 1B) in exon 11 (R419X). Restriction enzyme analysis with HpyCH4IV confirmed the finding and permitted a rapid analysis of samples (see figure 1C) . The 1,274C3 T mutation was absent on 400 chromosomes from 200 unrelated control individuals. There were no carriers of the mutation identified in the control samples. None of the unaffected individuals in the family was homozygous for the mutation. Obligate carriers and individuals identified as heterozygotes by linkage analysis 19 were also heterozygous for the mutation. Only affected individuals in the family were homozygous for the 1,274C3 T mutation ( figure 2) .
Description of gene (cereblon) for mild NSMR. The LOC51185 transcript was previously identified as part of a large-scale research effort to sequence human cDNA clones containing open reading frames. 22 The LOC51185 transcript contains 11 predicted exons and a putative protein product of 442 amino acids. There is a 237-amino acid ATP-dependent Lon protease domain and other motifs that include casein kinase II (CK2) phosphorylation, N-myristoylation, protein kinase C phosphorylation, and N-glycosylation sites (see figure 2) . The LOC51185 transcript was assigned the gene name cereblon (HUGO symbol CRBN) based on its putative role in cerebral development and the presence of its large, highly con- Figure 2 . Segregation of the CRBN mutation using HpyCH4IV restriction enzyme digestion of exon 11 in an abridged family pedigree. As in figure 1C , a single 331-bp band represents the wild-type allele and is homozygous in Individuals 2, 8, 10, 19, 24, 26, 30, and 31. Carriers (Individuals 1, 3, 4, 5, 6, 7, 9, 12, 15, 16, 20, 22, 27, 28, and 32) Individuals 11, 13, 14, 17, 18, 21, 23, 25, and 29 
show two bands representing the 331-bp wild-type allele and the cleaved mutant allele (164-bp, 167-bp). The mutation creates a restriction site so that the amplified 331-bp fragment is cleaved in half (164-bp, 167-bp) and is shown as a single lower band in affected

. Filled circles (females) and squares (males) represent affected individuals with mental retardation. Unaffected individuals are indicated by open symbols. Consanguineous marriages are indicated by double bars joining the individuals. For confidentiality reasons, the order and the sex of at-risk individuals are changed.
served Lon domain. The truncating mutation in the CRBN gene that causes a mild type of ARNSMR spares the Lon domain, interrupts an N-myristoylation site, and eliminates a CK2 phosphorylation site at the C terminus ( figure  3 ). Reverse transcription PCR demonstrated abundant expression of CRBN in the human brain (data not shown).
Discussion. Three lines of evidence strongly suggest that the mutation in the CRBN gene causes mild mental retardation. First, a small interstitial deletion of one allele involving the candidate interval for ARNSMR between loci D3S3630 and D3S1304 on chromosome 3p25-pter results in a viable human phenotype of ptosis, microcephaly, growth retardation, and mental retardation (3p syndrome). 23, 24 The extensive impairment in the 3p syndrome as compared with the mild mental retardation in our cases suggests that a loss of function of the CRBN gene and other genes within the interval has neurologic and cognitive consequences. The deletion of one copy of the CRBN gene in the 3p syndrome also indicates that haploinsufficiency of the CRBN gene is not lethal. Second, the nonsense mutation in the CRBN gene causes a severe alteration of the predicted protein structure by causing a stop codon that prematurely truncates the protein. As shown in figure 3 , the mutation disrupts an N-myristoylation site and deletes a CK2 phosphorylation motif. These disruptions may prevent proper subcellular targeting and alter long-term potentiation in the hippocampus. 25 Third, both the CRBN and another gene, PRSS15, encode for ATP-dependent Lon proteases that are highly expressed in the human brain. Although the PRSS15 gene has not been directly associated with human disease, its presence in the hippocampus 26 and its location in the candidate region for a severe form of ARNSMR 27 suggest a role in memory and learning. Most, if not all, human Lon-containing proteins are localized to the mitochondria where they selectively degrade short-lived polypeptides 28, 29 and regulate mitochondrial replication and transcription by specific binding to GT-rich mitochondrial DNA sequences. 30 Therefore, we hypothesize that a defect in the CRBN gene may perturb nuclear regulation of mitochondrial energy metabolism and cause memory and learning difficulties.
A truncating mutation in another gene, neurotrypsin, which is highly expressed in the hippocampus, causes an atypical type of severe ARNSMR in Algerians by altering proteolysis at the synaptic level. 7, 31 The phenotype in individuals with neurotrypsin mutations is characterized by normal psychomotor development during the first 2 years of life followed by a progressive cognitive deterioration leading to severe mental retardation with IQs of Ͻ50.
7 This phenotype is distinctly different from the mild mental retardation that we describe in individuals with a truncating mutation in the CRBN gene.
The discovery of CRBN as a gene that is involved in mild mental retardation will enable the development of a test for early diagnosis and prenatal counseling in the large population isolate that we have studied. 19 It will also focus research efforts to search for other mutations in the ATP-dependent Lon protease gene family as causes for ARNSMR. Although the pathogenic consequences caused by the truncating mutation in the CRBN gene are not clear, a partial loss of function of CRBN could alter longterm potentiation by affecting physiologic changes in the mitochondria. Confirming this hypothesis may provide opportunities for therapy and contribute to a better understanding of mitochondrial function and failure in other human neurologic disorders such as Friedreich ataxia, 32 Parkinson, and Alzheimer diseases. 33 More specifically, this discovery will clarify the basic mechanisms that are involved in mental retardation and facilitate research on the functional role of the CRBN gene in memory and learning. 
